Literature DB >> 33284874

Papillary thyroid carcinoma presenting as a functioning thyroid nodule: report of 2 rare cases.

Liang Hu1, Yijun Wu1.   

Abstract

INTRODUCTION: Autonomously functioning thyroid nodules (AFTNs) are generally benign, whereas papillary thyroid carcinomas (PTCs) are mostly non-functioning. Graves' disease (GD) is the most common cause of hyperthyroidism (HD), followed by hyperfunctional adenoma or Plummer's disease. GD with AFTNs is called Marine-Lenhart syndrome, a relatively rare syndrome. In clinical practice, the presence of HD, AFTNs and PTC at the same time is extremely rare. CASE
PRESENTATION: Case 1: A 55-year-old middle-aged woman with a preoperative diagnosis of GD and HD with right AFTNs. Case 2: A 43-year-old middle-aged woman with a preoperative diagnosis of non-GD and HD with right AFTNs and right PTC. Case 1: Histology showed a 4 cm adenoma with a 1.0 cm PTC in the right lobe and a 0.3 cm PTC in the left lobe. The rest of the thyroid showed typical pathologic GD changes. The postoperative diagnosis was atypical Marine-Lenhart syndrome with bilateral PTC. Case 2: Histology showed a 0.4 cm PTC surrounded by nodular goiter. The postoperative diagnosis was toxic nodular goiter with PTC.
CONCLUSION: This paper covers the relationships among PTC, HD and AFTNs, explains some common and uncommon clinical diagnoses, and reports two rare cases with these three diagnoses. Our ultimate purpose is to remind doctors that when handling nodules or HD, PTC as a diagnosis cannot be excluded. Instead, it is better to perform total or near-total thyroidectomy and intraoperative frozen biopsy or preoperative biopsy examinations to avoid omitting PTC, which needs reoperation. IJCEP
Copyright © 2020.

Entities:  

Keywords:  Hyperthyroidism; Marine-Lenhart syndrome; PTC; functioning nodule; thyroid carcinoma

Year:  2020        PMID: 33284874      PMCID: PMC7716118     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  51 in total

1.  Marine-Lenhart syndrome. Graves' disease with poorly functioning nodules.

Authors:  B Chandramouly; D Mann; R P Cunningham; E Giegerich
Journal:  Clin Nucl Med       Date:  1992-11       Impact factor: 7.794

Review 2.  Clinical practice. Graves' disease.

Authors:  Gregory A Brent
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

Review 3.  Thyrotropin in the development and management of differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Endocrinol Metab Clin North Am       Date:  2014-06       Impact factor: 4.741

4.  Graves' disease with functioning nodules (Marine-Lenhart syndrome).

Authors:  N D Charkes
Journal:  J Nucl Med       Date:  1972-12       Impact factor: 10.057

5.  Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism.

Authors:  S R Granter; E S Cibas
Journal:  Am J Clin Pathol       Date:  1997-01       Impact factor: 2.493

Review 6.  Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.

Authors:  Hulya Iliksu Gozu; Julia Lublinghoff; Rifat Bircan; Ralf Paschke
Journal:  Mol Cell Endocrinol       Date:  2010-02-06       Impact factor: 4.102

7.  Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.

Authors:  Guglielmo Ardito; Luca Revelli; Erika Giustozzi; Massimo Salvatori; Guido Fadda; Francesco Ardito; Nicola Avenia; Alice Ferretti; Lucia Rampin; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Clin Nucl Med       Date:  2013-01       Impact factor: 7.794

8.  Prevalence of thyroid cancer in hyperthyroidism treated by surgery.

Authors:  Chih-Hsin Lin; Feng-Yu Chiang; Ling-Feng Wang
Journal:  Kaohsiung J Med Sci       Date:  2003-08       Impact factor: 2.744

9.  Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer.

Authors:  Mehmet Uludag; Gurkan Yetkin; Bulent Citgez; Adnan Isgor; Tulay Basak
Journal:  Hormones (Athens)       Date:  2008 Apr-Jun       Impact factor: 2.885

10.  The prevalence of thyroid cancer in patients with hyperthyroidism.

Authors:  Fathimabeebi P Kunjumohamed; Noor B Al-Busaidi; Hilal N Al-Musalhi; Sulaiman Z Al-Shereiqi; Issa S Al-Salmi
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.